-
Loading metrics
Open Access
Peer-reviewed
Research Article
Interleukin-27 Is a Potent Inhibitor of cis HIV-1 Replication in Monocyte-Derived Dendritic Cells via a Type I Interferon-Independent Pathway
-
Qian Chen ,
Contributed equally to this work with: Qian Chen, Sanjay Swaminathan
Affiliation Laboratory of Human Retrovirology, Applied and Developmental Research Directorate (ADD), Science Application International Corporation (SAIC)-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America
⨯ -
Sanjay Swaminathan ,
Contributed equally to this work with: Qian Chen, Sanjay Swaminathan
Affiliation Laboratory of Human Retrovirology, Applied and Developmental Research Directorate (ADD), Science Application International Corporation (SAIC)-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America
⨯ -
De Yang,
Affiliation Laboratory of Molecular Immunoregulation, Basic Research Program Directorate, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America
⨯ -
Lue Dai,
Affiliation Laboratory of Human Retrovirology, Applied and Developmental Research Directorate (ADD), Science Application International Corporation (SAIC)-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America
⨯ -
Hongyan Sui,
Affiliation Laboratory of Human Retrovirology, Applied and Developmental Research Directorate (ADD), Science Application International Corporation (SAIC)-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America
⨯ -
Jun Yang,
Affiliation Laboratory of Immunopathogenesis and Bioinformatics, ADD, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America
⨯ -
Ronald L. Hornung,
Affiliation Immunological Monitoring Laboratory, ADD, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America
⨯ -
Yanmei Wang,
Affiliation Immunological Monitoring Laboratory, ADD, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America
⨯ -
Da Wei Huang,
Affiliation Laboratory of Immunopathogenesis and Bioinformatics, ADD, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America
⨯ -
Xiaojun Hu,
Affiliation Laboratory of Immunopathogenesis and Bioinformatics, ADD, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America
⨯ -
Richard A. Lempicki,
Affiliation Laboratory of Immunopathogenesis and Bioinformatics, ADD, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America
⨯ -
Tomozumi Imamichi
* E-mail: timamichi@mail.nih.gov
Affiliation Laboratory of Human Retrovirology, Applied and Developmental Research Directorate (ADD), Science Application International Corporation (SAIC)-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America
⨯
Interleukin-27 Is a Potent Inhibitor of cis HIV-1 Replication in Monocyte-Derived Dendritic Cells via a Type I Interferon-Independent Pathway
- Qian Chen,
- Sanjay Swaminathan,
- De Yang,
- Lue Dai,
- Hongyan Sui,
- Jun Yang,
- Ronald L. Hornung,
- Yanmei Wang,
- Da Wei Huang,
- Xiaojun Hu
- Published: March 20, 2013
- https://doi.org/10.1371/journal.pone.0059194